Napoli Shkolnik Canada has a proven record of representing municipal governments in the opioid litigation. Our U.S. affiliate has recovered billions of dollars for states, counties and municipalities.
Napoli Shkolnik Canada has filed a class action on behalf of Canadian municipalities to fund the abatement of the opioid crisis.
Contact us to learn more about how we can help your municipality.
Opioids claimed 34,455 deaths between January 2016 and September 2022.
According to the Canadian government’s Health Infobase, between January 2019 and September 2021, Canada experienced an average of 20 deaths per day related to opioid toxicity, with a peak of 21 deaths per day in 2021.
In 2017, enough oral solid opioids were prescribed to provide every Canadian with the equivalent of over 1 mg of morphine per day.
Drug overdoses accounted for approximately 17% of all deaths among Canadians aged 30 to 39 in 2019, and 13% of deaths among those aged 40 to 49.
There were more than 28,000 Emergency Medical Services (EMS) responses to suspected opioid-related overdoses in 2022 (January – September).
Unmasking the ripple effects of Canada’s opioid crisis reveals a harrowing reality of lives lost, crime surges, homelessness, and healthcare strain.
“Canadian government faces class action lawsuit for inadequate support amidst opioid crisis. Urgent need for comprehensive, equitable measures to tackle crisis.”
Canada grapples with a devastating opioid crisis affecting all demographics, leading to overdose deaths, addiction rates, and crime.
The opioid crisis in Edmonton persists despite declining numbers in Alberta. Efforts focus on naloxone distribution and education to combat the crisis effectively.
The opioid crisis in Canada has far-reaching implications, affecting public health, safety, and vulnerable populations. Urgent action is needed to address this escalating issue.
“The opioid crisis in Quebec demands immediate action and comprehensive strategies to combat the escalating health catastrophe.”
Phone: (888) 531-0675
Email: info@opioidclassaction.com
